[ad_1]
Patients use prophylaxis significantly at home in cases of minor illness such as inflammation, headaches and pain, but new studies suggest "hidden" damage to this "daily" medication.
In an article written by TV presenter Judy Finnegan in the Sunday Express, she confirmed that she "almost died" after taking "Proven" to relieve the pain of a knee injury.
Venegan said she took the tablets daily for 4 weeks, until she collapsed and began to defuse the blood, before being transferred to the hospital. , where he was treated by blood transfusion.
According to Fenigan, doctors reportedly told him that the prostate had created four giant vesicles in his stomach, one of which on the main artery of the heart, which had been severed and had almost caused his death.
According to the British Health Organization, this drug contributes to 2,000 deaths a year in Britain.
Health officials said the drug against spread was safe in general, but that a specific type of patient had to stay completely out of the way, including those who had previously had an ulcer. Who had heart problems or liver problems.
The British Health Organization said that people with asthma, Crohn's disease or high blood pressure should also stay out of "prophylaxis".
According to a recent study from Boston University, 15% of Americans take more than just prophylaxis, which could put them at risk.
In addition to some of the risks that Prophyl may present for people who have already suffered from the disease, this medicine is safe and cheap for the public, so doctors have recommended that they continue to use it, but with caution.
");
//}, 3000);
}
});
//$(window).bind('scroll & # 39;);
$ (window) .scroll (function () {
if (alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true;
// $ (window) .unbind (& # 39; scroll & # 39;);
// console.log ("loaded scroll");
(function (d, s, id) {
var js, fjs = d.getElementsByTagName (s)[0];
if (d.getElementById (id)) return;
js = d.createElement (s); js.id = id;
js.async = true;
js._https = true;
js.src = "http://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
// pre_loader ();
// $ (window) .unbind (& # 39; mousemove & # 39;);
// setTimeout (function () {
// $ (# boxTwitter & # 39;) .html ("Tweets by @tayyar_org");
//}, 3000);
var scriptTag = document.createElement ("script");
scriptTag.type = "text / javascript"
scriptTag.src = "http://www.tayyar.org/scripts/social.js";
scriptTag.async = true;
document.getElementsByTagName ("head")[0].appendChild (scriptTag);
(function () {
$ .getScript ("http://www.tayyar.org/scripts/social.js", function () {});
});
}
});
//$(window).load(function () {
// setTimeout (function () {
// // add the returned content to a newly generated script tag
// var se = document.createElement (& # 39; script & # 39;);
// se.type = "text / javascript";
// //se.async = true;
// se.text = "setTimeout (function () {pre_loader ();}, 5000);";
// document.getElementsByTagName (& # 39; body & # 39;)[0].appendChild (se);
//}, 5000);
//});
[ad_2]
Source link
